Pharmaceutical

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

Nov 9, 2024 - 06:00
In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

Santen, Arctic Vision sign deal for ARVN001 to treat UME

Next Article

Improving life science R&D outcomes with AI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more

STAT+: Pharmalittle: We are reading about Catalent conc...

Feb 9, 2024

AAIC 2024: the evolution of Alzheimer’s clinical trials

AAIC 2024: the evolution of Alzheimer’s clinical trials

Jul 30, 2024

Trump picks vaccine sceptic RFK Jr to lead HHS in new administration

Trump picks vaccine sceptic RFK Jr to lead HHS in new a...

Nov 15, 2024